Cydectin TriclaMox 1mg/ml + 50 mg/ml Oral Solution for sheep

Authorised

Triclabendazole
Moxidectin

Download as PDF

Product identification

Medicine name:

Cydectin TriclaMox 1mg/ml + 50 mg/ml Oral Solution for sheep

Active substance:

Triclabendazole
Moxidectin

Target species:

Sheep

Route of administration:

Oral use

Product details

Active substance and strength:

Triclabendazole

50.00

milligram(s)

/

1.00

millilitre(s)
Moxidectin

1.00

milligram(s)

/

1.00

millilitre(s)

Pharmaceutical form:

Oral solution

Withdrawal period by route of administration:

Oral use
- Sheep
  - Milk
    
    no withdrawal period
    
    Not authorised for use in ewes producing milk intended for human consumption including during the dry period. Do not use within 1 year prior to the first lambing in ewes intended to produce milk for human consumption.
  - Meat and offal
    
    31
    
    day

Anatomical therapeutic chemical veterinary (ATCvet) codes:

QP54AB52

Legal status of supply:

Veterinary medicinal product subject to veterinary prescription

Authorisation status:

Valid

Authorised in:

Ireland

Available in:

Ireland

Package description:

1 L bottle
5 L bottle
2.5 L bottle

Additional information

Entitlement type:

Marketing Authorisation

Legal basis of product authorisation:

Fixed combination application (Article 13b of Directive No 2001/82/EC)

Marketing authorisation holder:

Zoetis Belgium S.A.

Marketing authorisation date:

9/12/2013

Manufacturing sites for batch release:

Zoetis Manufacturing & Research Spain S.L.

Responsible authority:

Health Products Regulatory Authority

Authorisation number:

VPA10387/016/001

Date of authorisation status change:

9/12/2013

Reference member state:

France

Procedure number:

FR/V/0201/001

Concerned member states:

Austria
Belgium
Germany
Iceland
Ireland
Italy
Luxembourg
Netherlands
Portugal
Spain
Sweden
United Kingdom (Northern Ireland)

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet